John B. Green, Chief Financial Officer at Dicerna Pharmaceuticals Inc (DRNA), sold 12,500 shares at $21.05 ($263K) on 2019-11-18, disclosed to the SEC on 2019-11-20.
Open-market sale of $263k DRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DRNA | SELL | 2020-01-21 | $1.5M | — | Filing → |
| DRNA | SELL | 2019-11-27 | $312K | — | Filing → |
| DRNA | SELL | 2019-11-15 | $71K | — | Filing → |